Jubilant Biosys Limited to add Drug Discovery & Preclinical Development capabilities in Biologics and Antibody Drug Conjugate

Posted on by ddAdmin

Jubilant Biosys announce strategic joint venture with Pierre Fabre to acquire its R&D centre in France, to enter into Biologics (mABs) and ADCs

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness of campaigns and analyse traffic. If you continue to use this site we will assume your acceptance.

Ok Privacy Policy